Alnylam Pharmaceuticals
ALNY
#649
Rank
HK$307.78 B
Marketcap
HK$2,305
Share price
2.04%
Change (1 day)
-9.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company